MR编号 | FR/H/8065/001 |
---|
药品名称 | ACT-HIB |
---|
活性成分 | - haemophilus influenzae type b capsular polysaccharide conjugated to tetanus toxoid 10.0 µg/0,5ml
|
---|
剂型 | Powder and solvent for solution for injection |
---|
上市许可持有人 | Dummy PR created for all purely national authorised products included in the WS procedure FR/H/xxxx/WS/359
MA Holder: SANOFI PASTEUR |
---|
参考成员国 - 产品名称 | France (FR) ACT-HIB |
---|
互认成员国 - 产品名称 | - Germany (DE)
- Belgium (BE)
- Netherlands (NL)
- Luxembourg (LU)
- Iceland (IS)
- Austria (AT)
- Portugal (PT)
- Italy (IT)
- Greece (GR)
- Sweden (SE)
- Norway (NO)
- Finland (FI)
- Poland (PL)
|
---|
许可日期 | 2023/05/26 |
---|
最近更新日期 | 2023/06/23 |
---|
药物ATC编码 | - J07AG01 haemophilus influenzae B, purified antigen conjugated
|
---|
申请类型 | - TypeLevel1:[not specified]
- TypeLevel2:[not specified]
- TypeLevel3:[not specified]
- TypeLevel4:[not specified]
- TypeLevel5:[not specified]
|
---|
附件文件下载 | |
---|
市场状态 | Positive |
---|